Associations of oral α-, β-, and γ-human papillomavirus types with risk of incident head and neck cancer

JAMA Oncology

Volumn 2, Issue 5, 2016, Pages 599-606

  Agalliu, Ilir ^a   Gapstur, Susan ^b   Chen, Zigui ^a   Wang, Tao ^a   Anderson, Rebecca L ^b   Teras, Lauren ^b   Kreimer, Aimee R ^c   Hayes, Richard B ^d   Freedman, Neal D ^c   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85010705349     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.5504     Document Type: Article

References (45)

1. Howlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. J Natl Cancer Inst Monogr. 2014; 2014(49):255-264.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29.
3. Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99(10):777-789.
4. Pelucchi C, Gallus S, GaravelloW, Bosetti C, La Vecchia C. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev. 2008;17(4):340-344.
5. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirusrelated and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26(4):612-619.
6. Joseph AW, D'Souza G. Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am. 2012;45(4):739-764.
7. Chaturvedi AK. Global burden of human papillomavirus-positive head and neck cancers. Lancet Oncol. 2014;15(12):1282-1283.
8. Hobbs CG, Sterne JA, BaileyM, Heyderman RS, BirchallMA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31(4):259-266.
9. Oliveira MC. Andrade MD. Menezes FD. Epidemiology of HPV in head and neck cancer, human papillomavirus and related diseases. In: Broeck DV, ed. From Bench to Bedside: A Clinical Perspective. Rijeka, Croatia: InTech; 2012.
10. Ndiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319-1331.
11. Tran N, Rose BR, O'Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck. 2007;29(1):64-70.
12. Fakhry C, Psyrri A, Chaturvedhi A. HPV and head and neck cancers: state-of-the-science. Oral Oncol. 2014;50(5):353-355.
13. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-720.
14. Applebaum KM, Furniss CS, Zeka A, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst. 2007;99(23):1801-1810.
15. Chaturvedi AK. Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol. 2012;6(suppl 1):S16-S24.
16. Saulle R, Semyonov L, Mannocci A, et al. Human papillomavirus and cancerous diseases of the head and neck: a systematic review and meta-analysis. Oral Dis. 2015;21(4):417-431.
17. Ribeiro KB, Levi JE, Pawlita M, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol. 2011;40(2): 489-502.
18. Kreimer AR, Johansson M, Waterboer T, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013;31(21):2708-2715.
19. Michaud DS, Langevin SM, EliotM, et al. High-risk HPV types and head and neck cancer. Int J Cancer. 2014;135(7):1653-1661.
20. Bottalico D, Chen Z, Dunne A, et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis. 2011; 204(5):787-792.
21. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94(2):500-511.
22. Zhu CS, Pinsky PF, Kramer BS, et al. The Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial and its associated research resource. J Natl Cancer Inst. 2013;105(22):1684-1693.
23. Hayes RB, Sigurdson A, Moore L, et al; PLCO Trial Team. Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res. 2005; 592(1-2):147-154.
24. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCRmethods. J Med Virol. 2002;68(3):417-423.
25. Fonseca AJ, Taeko D, Chaves TA, et al. HPV Infection and Cervical Screening in Socially Isolated IndigenousWomen Inhabitants of the Amazonian Rainforest. PLoS One. 2015;10(7):e0133635.
26. Woolson RF, Lachenbruch PA. Regression analysis of matched case-control data. Am J Epidemiol. 1982;115(3):444-452.
27. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, PA; LippincottWilliams & Wilkins; 2008.
28. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: A Review of Human Carcinogens: Part B Biological Agents, Vol 100B. Lyon, France: 2012. http://monographs.iarc.fr/ENG /Monographs/PDFs/index.php. Accessed December 14, 2015.
29. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96(6):449-455.
30. Pintos J, Black MJ, Sadeghi N, et al. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol. 2008;44(3):242-250.
31. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19): 1944-1956.
32. Herrero R, Castellsague X, Pawlita M, et al; IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772-1783.
33. Tachezy R, Klozar J, Rubenstein L, et al. Demographic and risk factors in patients with head and neck tumors. J Med Virol. 2009;81(5):878-887.
34. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703.
35. Kreimer AR, Pierce Campbell CM, Lin HY, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382(9895):877-887.
36. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37(6): 386-391.
37. Iannacone MR, Gheit T, Pfister H, et al. Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer. 2014;134(9):2231-2244.
38. Neale RE, Weissenborn S, Abeni D, et al. Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22(4):719-727.
39. Forslund O, Iftner T, Andersson K, et al; Viraskin Study Group. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis. 2007;196(6):876-883.
40. Rusan M, Li YY, Hammerman PS. Genomic landscape of human papillomavirus-associated cancers. Clin Cancer Res. 2015;21(9):2009-2019.
41. Groves IJ, Coleman N. Pathogenesis of human papillomavirus-associated mucosal disease. J Pathol. 2015;235(4):527-538.
42. Quint KD, Genders RE, de Koning MN, et al. Human Beta-papillomavirus infection and keratinocyte carcinomas. J Pathol. 2015;235(2): 342-354.
43. Howley PM, Pfister HJ. Beta genus papillomaviruses and skin cancer. Virology. 2015; 479-480:290-296.
44. Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157-1160.
45. Vinzon SE, Rosl F. HPV vaccination for prevention of skin cancer. Hum Vaccin Immunother. 2015;11(2):353-357.